N-Acetyl Selank

N-Acetyl-Selank is an acetylated derivative of selank (TKPRPGP), a synthetic heptapeptide anxiolytic developed from a tuftsin-based sequence; N-acetylation at the N-terminus is proposed to improve resistance to enzymatic degradation and potentially alter blood-brain barrier permeability relative to the parent compound, with the expectation of enhanced CNS bioavailability and duration of action. The pharmacological rationale derives from the parent compound selank, which acts through GABAergic, serotonergic, and enkephalinergic pathways to produce anxiolytic and nootropic effects in preclinical models and limited Russian human clinical studies; N-acetyl-selank is presumed to retain similar receptor interactions with modified pharmacokinetics.

anxiolytic, cognitive enhancement, memory, stress reduction, mood stability.

Research on N-Acetyl Selank primarily documents effects related to anxiolytic and cognitive enhancement and memory and stress reduction and mood stability. These are areas covered in preclinical and clinical literature — individual response varies and effects depend on context of use.

For N-Acetyl Selank, it is designated for research use only. Regulatory status reflects publicly available information and may change. This is not legal or medical advice.

3 providers in the directory currently offer N-Acetyl Selank.

N-Acetyl Selank is tracked across 4 research vendors on PeptideBase, with per-mg prices ranging $2.45–$5.46. This reflects research-use vendor pricing, not clinical or prescription costs.